COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C, 5-FLUOROURACIL, AND CYTOSINE-ARABINOSIDE IN GASTROINTESTINAL CANCER

被引：0
作者：
DEJAGER, RL [1 ]
MAGILL, GB [1 ]
GOLBEY, RB [1 ]
KRAKOFF, IH [1 ]
机构：
[1] MEMORIAL SLOAN KETTERING CANC CTR,DEPT MED,CLIN CHEMOTHERAPY & SOLID TUMOR SERV,NEW YORK,NY 10021
来源：
CANCER TREATMENT REPORTS | 1976年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1373 / 1375
页数：3
相关论文
共 50 条
[41]   5-FLUOROURACIL, HIGH-DOSE FOLINIC ACID, AND MITOMYCIN-C COMBINATION CHEMOTHERAPY IN ADVANCED GASTROINTESTINAL ADENOCARCINOMAS - A PILOT-STUDY [J].
BECOUARN, Y ;
BRUNET, R ;
BUSSIERES, E ;
MAREE, D .
ONCOLOGY, 1988, 45 (04) :269-272
[42]   RANDOMIZED STUDY WITH MITOMYCIN-C PLUS 5-FLUOROURACIL PLUS CYTOSINE-ARABINOSIDE (MFC) PLUS 5-FLUOROURACIL, MFC PLUS TEGAFUR AND URACIL (UFT), AND MF PLUS UFT IN ADVANCED GASTRIC-CANCER - INTERINSTITUTIONAL DIFFERENCES IN A MULTICENTER STUDY IN JAPAN [J].
FURUKAWA, H ;
IWANAGA, T ;
NAKAJIMA, T ;
OKABAYASHI, K ;
NAKAZATO, H ;
HIRATSUKA, M ;
OHTA, K ;
KITO, T ;
YAMAMURA, Y ;
GOTO, S .
JOURNAL OF SURGICAL ONCOLOGY, 1995, 60 (01) :59-64
[43]   THE EFFECTS OF 5-FLUOROURACIL AND MITOMYCIN-C ON THE CORNEAL ENDOTHELIUM [J].
NUYTS, RMMA ;
PELS, E ;
GREVE, EL .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) :737-737
[44]   OCULAR TOXICITY OF MITOMYCIN-C AND 5-FLUOROURACIL IN THE RABBIT [J].
MORROW, GL ;
STEIN, RM ;
HEATHCOTE, JG ;
IKEDADOUGLAS, JV ;
FELDMAN, F .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1994, 29 (06) :268-273
[45]   THE EFFECTS OF 5-FLUOROURACIL AND MITOMYCIN-C ON THE CORNEAL ENDOTHELIUM [J].
NUYTS, RMMA ;
PELS, E ;
GREVE, EL .
CURRENT EYE RESEARCH, 1992, 11 (06) :565-570
[46]   PHARMACOLOGY OF INTRAPERITONEAL INFUSION 5-FLUOROURACIL AND MITOMYCIN-C [J].
GYVES, J .
SEMINARS IN ONCOLOGY, 1985, 12 (03) :29-32
[47]   COMBINATION CHEMOTHERAPY OF 5-FLUOROURACIL, EPIDOXORUBICIN AND MITOMYCIN-C IN THE PALLIATIVE TREATMENT OF LOCALLY ADVANCED AND OR METASTATIC ADENOCARCINOMA OF THE STOMACH [J].
GEBBIA, V ;
TESTA, A ;
VALENZA, R ;
LATTERI, M ;
BAJARDI, G ;
MASTRANDREA, G ;
CIPOLLA, C ;
PISCHEDDA, G ;
CURTO, G ;
CANNATA, G ;
GEBBIA, N ;
FLORENA, M .
JOURNAL OF CHEMOTHERAPY, 1994, 6 (02) :147-151
[48]   PHASE-II STUDY OF A 5-FLUOROURACIL, TENIPOSIDE AND MITOMYCIN-C COMBINATION CHEMOTHERAPY IN ADVANCED COLORECTAL CARCINOMAS [J].
BECOUARN, Y ;
CALABET, J ;
BRUNET, R .
TUMORI JOURNAL, 1988, 74 (01) :75-77
[49]   EFFECTIVENESS OF POSTOPERATIVE ADJUVANT THERAPY WITH CYTO-TOXIC CHEMOTHERAPY (CYTOSINE-ARABINOSIDE, MITOMYCIN-C, 5-FLUOROURACIL) OR IMMUNOTHERAPY (NEURAMINIDASE-MODIFIED ALLOGENEIC CELLS) IN THE PREVENTION OF RECURRENCE OF DUKES-B AND C COLON CANCERCY [J].
RAINER, H ;
KOVATS, E ;
LEHMANN, HG ;
MICKSCHE, M ;
RAUHS, R ;
SEDLACEK, HH ;
SEIDL, W ;
SCHEMPER, M ;
SCHIESSEL, R ;
SCHWEIGER, B ;
WUNDERLICH, M .
RECENT RESULTS IN CANCER RESEARCH, 1981, 79 :41-47
[50]   THE EFFICACY OF 5-FLUOROURACIL, MITOMYCIN-C, AND METHYL-CCNU IN ADVANCED GASTROINTESTINAL MALIGNANCY [J].
VAUGHN, CB ;
CHAPMAN, JL ;
GARLAND, M ;
PEDERSON, B ;
DEMITRISH, MM ;
CHINN, B ;
WARD, D ;
BRADY, PR .
ONCOLOGY, 1981, 38 (03) :129-133
12345